March 03, 2025

More States Fast Track Foreign-Trained Physicians

Since 2023, nine states have waived U.S. residency requirements for some foreign-trained physicians, with more states considering similar changes.

KFF Health News

February 25, 2025

FDA Delays Update on 'Healthy' Label

The finalization of new criteria for the "healthy" nutrient content claim on food labels has been delayed, allowing more time for regulatory review of standards that could significantly influence labeling practices and help reduce diet-related chronic diseases.

Conexiant

February 24, 2025

Game-Changer for Pfizer? Former FDA Drug Chief Takes Reins

Before leadership at the FDA, Dr. Patrizia Cavazzoni spent nearly 2 decades in the pharmaceutical industry.

Conexiant

February 21, 2025

FDA Approves First Cerebrotendinous Xanthomatosis Treatment

The FDA has approved Ctexli (chenodiol) as the first treatment for cerebrotendinous xanthomatosis, a rare lipid storage disorder.

Conexiant

February 21, 2025

FDA Ends Semaglutide Shortage, Updates Policy

FDA declares resolution of nationwide semaglutide injection shortage and outlines 60 to 90 day transition periods for compounding facilities while other GLP-1 medications remain in limited supply.

Conexiant

February 12, 2025

FDA Clears Rapid GI Test Panel for Gastroenteritis Detection

Clearance was granted to bioMérieux's BIOFIRE FILMARRAY GI Panel Mid, a 1-hour molecular test that can detect 11 common gastroenteritis-causing pathogens from a single stool sample.

Conexiant

February 07, 2025

FDA Approves Novel Antibiotic for cIAI

FDA approves aztreonam-avibactam, the first monobactam/β-lactamase inhibitor combination antibiotic, for treating complicated intra-abdominal infections in adults with limited treatment options.

Conexiant

February 06, 2025

FDA: Diabetes Device Alerts May Fail

FDA warns of safety risks associated with smartphone-connected diabetes devices, citing missed alerts leading to severe complications including death.

Conexiant

July 18, 2023

First Oral Medication to Treat Moderate-to-Severe Crohn’s Disease Earns FDA Approval

Upadacitinib, the first oral treatment for Crohn's disease, has been approved by the Food and Drug Administration. The approval came in part through a Mount Sinai-led clinical trial that showed it to be more efficacious than placebo.

Mount Sinai New York